Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

NCT05802173 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic

Interventions

DRUG: TDM-105795, 0.0025%
DRUG: TDM-105795, 0.02%
DRUG: TDM-105795 topical vehicle solution

Sponsor

Technoderma Medicines Inc.

Collaborators

[object Object]